DCP
HOLX

Distillate Capital Partners’s Hologic HOLX Stock Holding History

Distillate Capital Partners’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-124
Closed -$7.66K – 129
2025
Q1 		$7.66K Buy
+124
New +$8.22K ﹤0.01% 103
2023
Q1 		– Sell
-148
Closed -$11.1K – 66
2022
Q4 		$11.1K Buy
+148
New +$10.5K 1.02% 44

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Distillate Capital Partners's HOLX Position: Q2 2025 in Review

Distillate Capital Partners sold out of Hologic (HOLX) in Q2 2025, closing a stake of 124 shares — an estimated $7.66K sold.

Distillate Capital Partners first reported a position in HOLX in Q4 2022 and held it in 2 quarters. The position peaked at $11.1K in Q4 2022. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Distillate Capital Partners reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Distillate Capital Partners sold 124 Hologic shares in Q2 2025, an estimated $7.66K.
  • Distillate Capital Partners first reported a position in Hologic in Q4 2022 and held it in 2 quarters.
  • Distillate Capital Partners's Hologic position peaked at $11.1K in Q4 2022.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Distillate Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.